Stomach Cancer Exosome-based Detection

Completed

Conditions studied: Gastric Cancer, Gastric Adenocarcinoma, Gastric Cancer Stage, Gastric Neoplasm, Gastric Lesion, Gastric Cancer in Situ, Gastric Cancer Stage IV, Gastric Cancer Stage IIIB, Gastric Cancer Stage III, Gastric Cancer Stage IB, Gastric Cancer Stage IA, Gastric Cancer, Stage 0, Gastric Cancer Stage IIIA, Gastric Cancer Stage II, Gastric Cancer TNM Staging, Gastric Cancer Metastatic to Lung, Gastric Cancer Metastatic to Liver, Gastric Cancer Stage I, Gastric Cancer TNM Staging Primary Tumor (T) T2B

In brief

Gastric cancer continues to have a poor prognosis primarily due to the inability to detect it in its early stages. This study will develop and validate a blood assay to facilitate the non-invasive detection of gastric cancer.

Key facts

Study ID

NCT06342427

Run by

City of Hope Medical Center

People needed

809

Starts

2023-03-15

Expected to finish

2024-06-15

Last updated by the study team

2024-07-08

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Histological diagnosis of stage I, II, III, IV gastric cancer (TNM classification, 8th edition) (cases).
• Received standard diagnostic and staging procedures as per local guidelines, and at least one sample was drawn before receiving any curative-intent treatment.
• Confirmed cancer-free status at the time of study inclusion (Non-disease controls).

You may not qualify if…

• Lack of written informed consent.
• Systemic therapy before sampling.
• Synchronous gastric and non-gastric cancer diagnosed at or before surgery.

Where it is running

• City of Hope Medical Center — Duarte, California, United States
• Nagoya University — Nagoya, Japan
• Mie University — Tsu, Japan

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.